by NYU Langone Health Credit: Unsplash/CC0 Public Domain The combination of an experimental mRNA vaccine with an immunotherapy reduced the likelihood of melanoma recurring or causing death by 44% when compared to immunotherapy alone, a new clinical trial shows. Led by researchers at NYU Langone Health and its Perlmutter Cancer Center, the randomized phase 2b trial involved men...
Tag: <span>melanoma recurrence</span>
Post
Researchers discover how to boost vaccine designed to prevent melanoma recurrence
by The Mount Sinai Hospital Melanoma in skin biopsy with H&E stain — this case may represent superficial spreading melanoma. A vaccine created to prevent the recurrence of the deadly skin cancer melanoma is about twice as effective when patients also receive two components that boost the number and effectiveness of immune system cells called dendritic...